<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003045'>Fibrosis</z:mp> of the bone marrow may be present in various <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> such as <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) and <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> is a relatively rare event </plain></SENT>
<SENT sid="2" pm="."><plain>Patients affected by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) present intriguing features that give rise to the hypothesis that H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> might represent a new entity </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this concise review is to summarize the contrasting opinions of the authors who have described some series of H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>Many characteristics induce one to distinguish H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> from classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, so that the former has been considered each time as a transitional stage between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>, an <z:hpo ids='HP_0011009'>acute</z:hpo> transformation of an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>, or an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> from the beginning </plain></SENT>
<SENT sid="5" pm="."><plain>The pathogenetic mechanism of the <z:mp ids='MP_0003045'>fibrosis</z:mp> of the bone marrow may be similar to sic sic of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> in which a stimulus to secrete <z:chebi fb="0" ids="26533">reticuline</z:chebi> or collagen derives from abnormal marrow megakaryocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Importance of karyotype abnormalities are discussed </plain></SENT>
<SENT sid="7" pm="."><plain>Clinical features of the syndrome are rather <z:hpo ids='HP_0001425'>heterogeneous</z:hpo>; evaluation of the survival of the described single cases reveals that mean survival is not significantly different from classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, trephine biopsy and the cytogenetic study are necessary to permit the diagnosis of H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>However, because of the relatively low number of cases, series of patients are necessary to correctly classify this syndrome </plain></SENT>
</text></document>